Erratum to: The effect of dabigatran and rivaroxaban on platelet reactivity and inflammatory markers.
Department of Cardiology, Rabin Medical Center, Petah-Tikva, and the Sackler Faculty of Medicine, Tel-Aviv University, Tel Aviv, Israel.
Noa
N
Zemer-Wassercug
Department of Cardiology, Meir Medical Center, Kfar Saba, and the Sackler Faculty of Medicine, Tel-Aviv University, Tel Aviv, Israel.
Moti
M
Haim
The Felsenstein Medical Research Center, Rabin Medical Center, Petah-Tikva, and the Sackler Faculty of Medicine, Tel-Aviv University, Tel Aviv, Israel.
Dorit
D
Leshem-Lev
Department of Cardiology, Rabin Medical Center, Petah-Tikva, and the Sackler Faculty of Medicine, Tel-Aviv University, Tel Aviv, Israel.
Katia L
KL
Orvin
Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Muthiah
M
Vaduganathan
Department of Cardiology, Rabin Medical Center, Petah-Tikva, and the Sackler Faculty of Medicine, Tel-Aviv University, Tel Aviv, Israel.
Ariel
A
Gutstein
Department of Cardiology, Rabin Medical Center, Petah-Tikva, and the Sackler Faculty of Medicine, Tel-Aviv University, Tel Aviv, Israel.
Ehud
E
Kadmon
Department of Cardiology, Rabin Medical Center, Petah-Tikva, and the Sackler Faculty of Medicine, Tel-Aviv University, Tel Aviv, Israel.
Aviv
A
Mager
Department of Cardiology, Rabin Medical Center, Petah-Tikva, and the Sackler Faculty of Medicine, Tel-Aviv University, Tel Aviv, Israel.
Ran
R
Kornowski
Department of Cardiology, Rabin Medical Center, Petah-Tikva, and the Sackler Faculty of Medicine, Tel-Aviv University, Tel Aviv, Israel. elil@clalit.org.il.
Eli I
EI
Lev